1. Introduction {#s0005}
===============

*Streptococcus suis* is an emerging zoonotic human pathogen. *S. suis* infection is acquired through exposure to contaminated pigs or pig meat. Healthy pigs can carry multiple serotypes of *S. suis* in their nasal cavities, tonsils, and upper respiratory, genital, and alimentary tracts. Based on differences in antigenic properties of the polysaccharide capsule, 33 serotypes have been distinguished to date, of which only a limited number are responsible for infections in pigs, including serotypes 1 to 9 and 14. Serotype 2 is considered to be the most pathogenic for both humans and pigs and is the single most common serotype found in human infection ([@bb0020]).

Over the past few years, the number of reported *S. suis* infections in humans has increased substantially, with most cases originating in Southeast Asia where there is a high density of pigs. Increased awareness, particularly following the occurrence of an outbreak of human and pig infection in the Sichuan province in China in 2005, has likely contributed to this increase in reported human infections ([@bb0060; @bb0085]). Meningitis and septicemia are the most common clinical manifestations of human *S. suis* infection; hearing loss is a frequent complication ([@bb0070]).

Although *S. suis* can be cultured from cerebrospinal fluid (CSF) or blood samples with use of standard microbiological techniques, infection often goes undiagnosed or positive cultures are misidentified as *Streptococcus* species, alpha-hemolytic or viridans streptococci, *Enterococcus faecalis*, *Aerococcus viridans*, or *Streptococcus pneumoniae* ([@bb0015; @bb0030]). Furthermore, culture results can be negative as a result of antibiotic use before the collection of specimens.

During a randomized placebo-controlled clinical trial on the adjuvant use of dexamethasone in adult patients with bacterial meningitis, carried out at the Hospital for Tropical Diseases in Ho Chi Minh City, Vietnam, *S. suis* serotype 2 was found to be the most common pathogen isolated from CSF cultures ([@bb0045]). As up to 60% of patients had used antimicrobial agents before submission to the hospital, and culture results were negative for 50% of patients ([@bb0045]), an internally controlled diagnostic real-time PCR was set up for detection of *S. suis* serotype 2 to further study the importance of this pathogen in patients with bacterial meningitis in this region. Here we report the design of this method and its prospective evaluation.

2. Materials and methods {#s0010}
========================

2.1. Sample collection {#s0015}
----------------------

This study was performed at the Hospital for Tropical Diseases, a tertiary referral hospital for infectious diseases. CSF samples were collected and stored as part of a randomized placebo-controlled clinical trial carried out at the Hospital for Tropical Diseases between November 1996 and May 2005 ([@bb0045]). CSF samples were sent for biochemical and microbiological investigations, and an aliquot was stored at −70 °C in a dedicated freezer on the ward. These samples were studied retrospectively. CSF samples were prospectively collected from all consecutive adult patients (age ≥15 years) presenting with fever and neck stiffness and/or altered consciousness at the Hospital for Tropical Diseases from May 2006 until June 2009, and were aliquoted immediately after lumbar puncture on the ward. Aliquots were sent to the biochemistry and microbiology laboratories for immediate processing and analyses. A separate aliquot was sent to the molecular diagnostics laboratory, where samples where stored for a maximum of 48 h at −70 °C until testing (prospective study). Standard measures for prevention of PCR contamination are operational at the molecular diagnostic laboratory, including a unidirectional workflow in physically separated laboratories for reagent preparation, nucleic acid extraction, and amplification and analysis, respectively.

Demographic, clinical, and laboratory data were recorded for all patients. The study was approved by the ethical review boards of the Hospital for Tropical Diseases and the University of Oxford (OXTREC).

2.2. Bacterial culture {#s0020}
----------------------

All CSF samples were spun down and a Gram stain was made. The pellet was inoculated on blood and chocolate agar plates and in brain heart infusion broth for enrichment. Plates were incubated at 37 °C in 5% CO~2~ for 18 h. The broth was incubated aerobically and subcultured if growth was present. Bacteria were identified using standard identification methods. *S. suis* was identified on the basis of colony morphology, negative catalase reaction, optochin resistance, and APIStrep (Biomerieux, Ho Chi Minh City, Vietnam). Serotyping was performed by slide agglutination with use of specific antisera (Statens Serum Institute, Copenhagen, Denmark).

Blood culture was performed using the BACTEC 9050 system, and positive culture results were identified as described above.

2.3. Primers and probes {#s0025}
-----------------------

Primers and probe for *S. suis* serotype 2 real-time PCR were designed using Primer Express Software and BLAST analysis, and were targeted at the *cps2J* gene ([@bb0050; @bb0055]), which is part of the operon encoding the serotype 2 and serotype 1/2 specific polysaccharide capsule of *S. suis*. Primers cps2JF (GGTTACTTGCTACTTTTGATGGAAATT) and cps2JR (CGCACCTCTTTTATCTCTTCCAA) and probe (FAM-TCAAGAATCTGAGCTGCAAAAGTGTCAAATTGA-TAMRA) were used for amplification and detection of an 88-bp amplicon. Primers and probes for real-time PCR for detection of *S. pneumoniae*, *Haemophilus influenzae* type b, and *N. meningitidis* were as described by [@bb0010] except that for all probes, FAM (6-carboxyfluorescein) and TAMRA were used as reporter and quencher, respectively.

Primers and probe for detection of internal control (IC) DNA (see below) were as described by [@bb0065]. The IC probe was labeled with Cy5 and BHQ1.

2.4. Internal control {#s0030}
---------------------

The efficiency of the DNA extraction and the amplification during the PCR was monitored using an IC, consisting of a pretest determined concentration of Phocid herpesvirus. IC was added to all samples before DNA extraction, as described by [@bb0065]. Concentration of IC was such that after efficient extraction and amplification, a Cy5 cycle threshold value (Ct value) between 33 and 37 should be expected for the IC-specific PCR reaction. Higher Ct values or negative results were interpreted as loss of DNA during extraction or inhibition of the PCR assay, in which case extraction and amplification were repeated. PhHV was kindly provided by M. Schutten (EMC, Rotterdam, the Netherlands).

2.5. DNA extraction of pure cultures and CSF samples {#s0035}
----------------------------------------------------

A 100-μL aliquot of a bacterial suspension or of unspun CSF was treated with 0.1 volume of prelysis buffer (1% SDS, 5% Tween 20, and 5% Sarkosyl in 1× TE) at 37 °C for 1 h. A 20-μL volume of IC at a predetermined concentration was added to the sample, and DNA was extracted by manual extraction (retrospective study) or automated extraction using the EasyMag extraction system (BioMerieux, Ho Chi Minh City, Vietnam), according to manufacturer\'s instructions (prospective study). The manual extraction was performed as described by [@bb0005], using lysis buffer L7 that contains 1 mg/mL α-casein. The DNA was eluted in a final volume of 100 μL.

2.6. PCR components and amplification {#s0040}
-------------------------------------

The final PCR volume was 25 μL. The PCR mix consisted of 5 mmol/L MgCl~2~, 0.2 mmol/L each deoxynucleoside triphosphates dATP, dCTP, dGTP, dUTP, and 1 U of Hot Start Taq DNA polymerase (Qiagen, Hanoi, Vietnam) to which 5 μL of extracted DNA was added. Final concentrations of the 2 primers and probe sets for target and IC were 0.4 μmol/L of each primer and 0.1 μmol/L of each probe. PCR amplification conditions consisted of 15 min at 95 °C and 45 cycles of 30 s at 95 °C, 30 s at 60 °C, and 30 s at 72 °C in a Chromo 4 Real-time PCR system (Biorad, Ho Chi Minh City, Vietnam). Negative (no-template) controls of both extraction and PCR were included in each run.

The PCR was considered positive if negative controls were all negative and a FAM signal with a Ct value of ≤40 could be obtained from the sample. A PCR was considered negative if negative controls were all negative, and the IC showed a Cy5 Ct value within the expected range, and a FAM signal could not be obtained from the sample or the Ct value was \>40. Any PCR that yielded a FAM Ct value \>35 was repeated in duplicate for confirmation. The PCR was considered indeterminate if the IC showed a Cy5 Ct value outside of the expected range and a FAM signal could not be obtained or the Ct value was \>40, in which case DNA extraction and the PCR were repeated as described before.

The sensitivity and specificity of the PCR assay were determined on the basis of PCR results in bacterial culture-confirmed samples. PCR for *S. suis* serotype 2 was run on all culture-positive samples, including those growing *S. suis*, *S. pneumoniae*, *N. meningitidis*, *H. influenzae*, or other pathogens ([Tables 2 and 3](#t0010 t0015){ref-type="table"}).

2.7. Analytical sensitivity {#s0045}
---------------------------

To determine the detection limit of the assay, including the DNA extraction, a 10-fold serial dilution of a 0.5 McFarland suspension of *S. suis* serotype 2 strain 31533, kindly provided by M. Gottschalk (Montreal, Canada), was prepared in Todd Hewitt Broth. Fifty microliters of each dilution was spread out on blood agar plates in triplicate and incubated at 37 °C in 5% CO~2~ overnight for colony counting. A 100-μL volume of each dilution was used for DNA extraction in triplicate, in the absence and presence of IC. Five microliters of DNA was used for real-time PCR, as described above.

3. Results {#s0050}
==========

The PCR assay detected *S. suis* serotype 2 at a concentration of 2 × 10^2^ colony-forming units (CFUs) per milliliter, resulting in an analytical sensitivity of 1--5 CFUs per reaction. This analytical sensitivity did not vary in the presence or absence of IC DNA ([Table 1](#t0005){ref-type="table"}).

Sensitivity of the PCR was 100% when tested against 114 stored samples from culture-confirmed cases of meningitis with *S. suis* serotype 2 ([Table 2](#t0010){ref-type="table"}A). The PCR was negative in all 99 samples that were culture-positive for other bacterial pathogens, including *S. suis* of other serotypes (100% specificity, [Table 2](#t0010){ref-type="table"}A). All PCR-negative samples gave Ct values for the IC within the expected range.

Stored CSF samples that were culture positive for *S. pneumoniae*, *N. meningitidis*, and *H. influenzae* type b were also subjected to real-time PCR for specific detection of these pathogens. Of 50 samples culture positive for *S. pneumoniae*, 48 were positive in the PCR for detection of *S. pneumoniae* DNA, while all 11 samples culture positive for *N. meningitidis* and all 4 samples positive for *H. influenzae* type b were also positive in the respective specific PCRs.

During the study period, we admitted 248 consecutive patients with a clinical suspicion of bacterial meningitis. Demographic, clinical, and outcome characteristics of these 248 patients are shown in [Table 3](#t0015){ref-type="table"}. CSF samples from 238 patients were prospectively studied using bacterial culture and real-time PCR for detection of *S. suis* serotype 2, *N. meningitidis*, *H. influenzae* type b, and *S. pneumoniae*. A lumbar puncture was contraindicated in one patient because of risk of brain herniation. CSF samples were erroneously not sent for PCR analysis for the remaining 9 patients.

All 55 *S. suis* serotype 2 culture-positive samples collected prospectively on admission were also positive in the *S. suis* serotype 2-specific PCR. The admission CSF sample of one patient with culture-confirmed *S. suis* serotype 2 meningitis was not available for PCR analysis and PCR result of the second CSF sample from this patient (collected after 5 days of antibiotic treatment) was negative. The *S. suis* serotype 2 specific PCR was negative in all 39 samples, which were culture confirmed with other bacterial pathogens, including *S. suis* of other serotypes ([Table 2](#t0010){ref-type="table"}B).

*S. suis* was the most commonly identified pathogen ([Table 4](#t0020){ref-type="table"}). PCR for *S. suis* serotype 2 was positive in 101 of 238 (42.4%) samples, of which 55 (23.1%) were culture positive. *S. pneumoniae* and *N. meningitidis* were detected in 37 (15.5%) and 11 (4.6%) patients of which 16 (6.7%) and 4 (1.7%) were culture positive, respectively. *Listeria* species were cultured from CSF of 4 patients. Infections with multiple bacterial species were not detected. All samples gave the expected results for the IC. Bacterial pathogens were detected in 183 of 248 (73.8%) adult patients suspected of bacterial meningitis when combining results of Gram stain, bacterial culture and PCR on CSF, and blood culture.

CSF was significantly more often culture negative in patients who were pretreated with antimicrobial agents before admission ([Table 5](#t0025){ref-type="table"}). In contrast, detection rates by PCR were similar in patients who were pretreated and those who were not, although Ct values were significantly higher in patients who had received antimicrobial agents before collection of the CSF sample ([Table 5](#t0025){ref-type="table"}). We compared characteristics between patients who were only positive by PCR in CSF and those of whom CSF or blood samples were also culture positive ([Table 6](#t0030){ref-type="table"}). Patient characteristics related to exposure and clinical presentation were highly similar between the two groups, with the exception of a higher age and a higher prevalence of diabetes mellitus in patients who were PCR-positive only. In contrast, the median duration of illness was significantly longer and pretreatment with antimicrobial agents significantly more common in patients who were PCR-positive only. This was also reflected by lower CSF neutrophil counts, higher CSF glucose levels, and lower CSF lactate levels in the latter patients ([Table 6](#t0030){ref-type="table"}).

4. Discussion {#s0055}
=============

Human infections with *S. suis* are increasingly reported from various geographical areas. *S. suis* serotype 2 is the most common pathogen detected in adult patients with acute bacterial meningitis in Vietnam ([@bb0035; @bb0075]). While *S. suis* is not difficult to culture on blood agar plates supplemented with 5% CO~2~, CSF cultures may remain negative because of prior use of antimicrobial agents or low bacterial load. We developed a highly sensitive and specific real-time PCR for detection of *S. suis* serotype 2 in CSF. We designed primers targeted at the *cps2J* gene, which encodes a putative glycosyl transferase involved in the formation of the serotype 2 capsular polysaccharide. This gene was also used by other investigators as a target for conventional PCR for specific detection of *S. suis* serotype 2 in tonsillar and other pig samples ([@bb0080]). The *cps2J* gene is present in strains of serotype 2 and of serotype 1/2. Serotyping confirmed the presence of *S. suis* serotype 2 in all culture-positive CSF samples, and none contained serotype 1/2. To our knowledge, *S. suis* serotype 1/2 infection has never been reported in humans. So far, serotype 2 is the cause of more than 95% of reported human *S. suis* infections ([@bb0070]), and only sporadic single cases of patients infected with *S. suis* serotypes 1, 4, and 16 have been described ([@bb0040; @bb0070]). However, one patient in our retrospective analysis and 2 patients in the prospective analysis were infected with *S. suis* serotype 14. As expected, these samples were negative in the PCR. While the absolute number of patients reported with *S. suis* serotype 14 infection is still very low, this serotype appears to contribute consistently to the infectious burden of *S. suis* as reported in Thailand ([@bb0025]) and also observed in our study. While serotype 2 by far remains the predominant strain associated with human infection at present, inclusion of additional primer sets for detection of serotype 14 or generic detection of *S. suis* may therefore be considered in the future.

Our assay showed 100% sensitivity against samples that were culture positive for *S. suis* serotype 2, while analysis of CSF samples that were culture or PCR-positive for other pathogens than *S. suis* serotype 2, including *S. pneumoniae*, *N. meningitidis*, and *H. influenzae*, indicated 100% specificity of the assay. Thus, in a tertiary referral setting in southern Vietnam, the positive and negative predictive values of the test are 100%. Results of real-time PCR for specific detection of *S. pneumoniae*, *N. meningitidis*, and *H. influenzae* on samples studied retrospectively, which had been culture positive for these pathogens, showed that bacterial DNA was still detectable in 97% of samples indicating that the bacterial DNA was not affected by storage.

Prospective evaluation showed a striking additional diagnostic value of the *S. suis* serotype 2 PCR over culture, further strengthening observations that the prevalence of *S. suis* infections among Vietnamese patients with bacterial meningitis is extremely high. The diagnostic yield increased by 84% for patients with *S. suis* serotype 2 infection when using PCR. Similar differences in detection rates between culture and PCR were found for *S. pneumoniae* and *N. meningitidis*. In large part, these differences can be explained by the use of antimicrobial agents before admission and collection of specimens. In our study, overall 63.3% of patients had received antibiotics before admission, and this proportion was significantly higher in patients with culture-negative CSF samples. Furthermore, bacterial loads as assessed by Ct values in our PCR were significantly lower in pretreated patients. However, while PCR is clearly an important tool in the diagnosis of bacterial meningitis, it should not replace Gram stain and bacterial culture, given the need of a rapid presumptive diagnosis and antimicrobial susceptibility data in the treatment of this life-threatening disease. In addition, the pathogens that can be detected using PCR generally do not cover the full spectrum of potential causes of bacterial meningitis, indicating the continued need of bacterial culture.

*S. suis* was detected at much higher rates than *S. pneumoniae* and *N. meningitidis* in our study population. *S. suis* is increasingly recognized as an important cause of bacterial meningitis in adults, not only in Vietnam but also in China, Thailand, Singapore, and other countries in the region, while sporadic cases are reported worldwide. Risk factors for *S. suis* infection include (occupational) exposure to pigs and pig products. Consumption of undercooked pork products is increasingly being suggested as an additional risk factor for *S. suis* infection ([@bb0070]). The mortality of *S. suis* infection varies with the clinical presentation, with the lowest mortality in patients with meningitis and the highest mortality in those presenting with a streptococcal toxic shock-like syndrome ([@bb0070]). Resistance to penicillin in *S. suis* is extremely rare. All cultured strains in our study were sensitive to penicillin and ceftriaxone, which are the drugs of choice for treatment of *S. suis* meningitis. *S. suis* meningitis is commonly associated with neurologic sequelae, in particular hearing loss, which can be found in up to 60% of cases ([@bb0035]). To reliably determine the burden of disease caused by *S. suis* infection, while taking into account that over-the-counter sales of antimicrobial agents is common in regions where *S. suis* infections predominantly occur, the availability of sensitive and specific diagnostic tools to detect *S. suis* infections is extremely important. To our knowledge, this is the first prospective study on the molecular diagnosis of *S. suis* infections in humans.

In conclusion, we developed a highly sensitive and specific real-time PCR for detection of *S. suis* serotype 2 in CSF, which is now routinely used in a setting where human *S. suis* serotype 2 infection is endemic.

This work was supported by the Wellcome Trust Major Overseas Program in Vietnam.

###### 

Comparative analytical sensitivities of *S. suis* serotype 2 primers in the presence and absence of IC DNA

  IC DNA    Mean Ct value at the following bacterial concentration           
  --------- -------------------------------------------------------- ------- -------
  Present   29.99                                                    33.25   36.78
  Absent    30.21                                                    33.19   36.80

###### 

Sensitivity and specificity of *S. suis* serotype 2 PCR on culture-confirmed CSF samples, retrospective study (A) and prospective study (B)

  A.                             No. of samples   PCR positive   PCR negative
  ------------------------------ ---------------- -------------- --------------
  *S. suis* serotype 2           114              114            0
  *S. suis* serotype 14          1                0              1
  *N. meningitidis*              11               0              11
  *Neisseria* species            1                0              1
  *S. pneumoniae*                50               0              50
  *H. influenzae*                5                0              5
  *Streptococcus bovis*          2                0              2
  *Streptococcus agalactiae*     1                0              1
  Streptococci, viridans group   6                0              6
  *Staphylococcus aureus*        2                0              2
  *Escherichia coli*             8                0              8
  *Klebsiella pneumoniae*        10               0              10
  *Proteus mirabilis*            1                0              1
  *Pseudomonas aeruginosa*       1                0              1
  Total                          213              114            99
                                                                 

  B.                           No. of samples   No. of PCR positive   No. of PCR negative
  ---------------------------- ---------------- --------------------- ---------------------
  *S. suis* serotype 2         55               55                    0
  *S. suis* serotype 14        2                0                     2
  *S. suis*, untypeable        1                0                     1
  *N. meningitidis*            4                0                     4
  *S. pneumoniae*              16               0                     16
  *H. influenzae*              1                0                     1
  *Streptococcus agalactiae*   1                0                     1
  Nonhemolytic streptococci    1                0                     1
  *Staphylococcus aureus*      1                0                     1
  *Escherichia coli*           3                0                     3
  *Klebsiella pneumoniae*      2                0                     2
  *Acinetobacter* spp.         1                0                     1
  *Enterococcus avium*         1                0                     1
  *Listeria* spp.              4                0                     4
  *Salmonella* spp.            1                0                     1
  Total                        94               55                    39

###### 

Demographic, clinical, and outcome characteristics of 248 patients included in prospective study

  Characteristics                                             Frequency (%) *N* = 248
  ----------------------------------------------------------- -------------------------
  Age (years), median (interquartile range)                   46.5 (34--59)
  Sex, male                                                   181 (73.0)
  Occupation                                                  
   Farmer                                                     79 (31.9)
   Worker                                                     35 (14.1)
   Student                                                    4 (1.6)
   Seller                                                     22 (8.9)
   Occupation related to pigs                                 
    ✓ Butcher                                                 7 (2.8)
    ✓ Slaughterer                                             6 (2.4)
    ✓ Pig breeder                                             4 (1.6)
   Housewife                                                  14 (5.7)
   Other                                                      32 (12.9)
   No job                                                     45 (18.2)
  Underlying diseases/predisposing factors                    
   Diabetes mellitus                                          19 (7.7)
   Alcoholism                                                 18 (7.3)
   Otitis media                                               6 (2.4)
   Splenectomy                                                2 (0.8)
   Head trauma                                                26 (10.5)
   Cardiovascular diseases[a](#tf0005){ref-type="table-fn"}   17 (6.9)
   Pig/pork exposures[b](#tf0010){ref-type="table-fn"}        51 (20.6)
   HIV/AIDS                                                   4 (1.6)
  Used intravenous antibiotics before admission               157 (63.3)

Valvular heart diseases, atrial fibrillation.

Occupation related to pig/pork, eating pig\'s intestines and fresh blood, etc.

###### 

Results of Gram stain, culture, and real-time PCR for detection of *S. suis* serotype 2, *S. pneumoniae*, *H. influenzae* type b, and *N. meningitidis* on CSF samples, and blood culture, prospective study

                                 No. of positive specimens                                                                                     
  ------------------------------ --------------------------- ------------------------------------- -------------------------------------- ---- -----
  *S. suis* serotype 2           50                          61[a](#tf0015){ref-type="table-fn"}   101[a](#tf0015){ref-type="table-fn"}   34   107
  *S. suis* serotype 14          1                           2                                     0                                      1    2
  *S. suis* untypeable           1                           1                                     0                                      0    1
  *N. meningitidis*              4                           4                                     11                                     2    11
  *S. pneumoniae*                9                           16                                    37[b](#tf0020){ref-type="table-fn"}    8    39
  *H. influenzae*, nontypeable   0                           1                                     0                                      1    1
  *Streptococcus bovis*          1                           1                                     nd[c](#tf0025){ref-type="table-fn"}    0    1
  *Streptococcus agalactiae*     2                           1                                     0                                      2    2
  β-Hemolytic streptococci       0                           0                                     0                                      1    1
  Nonhemolytic streptococci      0                           1                                     0                                      1    1
  *Staphylococcus aureus*        1                           1                                     0                                      3    3
  *Escherichia coli*             1                           3                                     0                                      2    3
  *Klebsiella pneumoniae*        2                           4                                     0[d](#tf0030){ref-type="table-fn"}     1    4
  *Acinetobacter* spp.           0                           1                                     0                                      0    1
  *Enterococcus avium*           0                           1                                     0                                      0    1
  *Listeria* spp.                1                           4                                     0                                      2    4
  *Salmonella* spp.              0                           1                                     0                                      0    1
  Total                          73                          103                                   149                                    58   183

nd = not done.

CSF samples were unavailable for PCR for 6 patients.

*S. pneumoniae*-specific PCR was negative in 1 patient; CSF sample unavailable for PCR for 1 patient.

CSF sample unavailable for PCR.

CSF sample unavailable for PCR for 2 patients.

###### 

Result of CSF investigations for *S. suis* serotype 2, *S. pneumoniae*, *N. meningitidis*

  Antimicrobial agents before admission   Result of CSF investigations for *S. suis* serotype 2, *S. pneumoniae*, *N. meningitidis*                                         
  --------------------------------------- ------------------------------------------------------------------------------------------- -------------- ---------------------- ---------
  Used                                    34/98 (34.7)                                                                                97/97 (100)    27.78 (15.39--38)      \<0.001
  Not used                                39/47 (82.0)                                                                                42/43 (97.7)   24.66 (19.76--31.24)   
  Unknown                                 8/11 (72.7)                                                                                 10/11 (90.9)   24.57 (20.76--29)      

Cycle treshold value of real-time PCR.

Difference between Ct values for antimicrobial agents used versus not used, Wilcoxon rank-sum test.

###### 

Characteristics of patients with *S. suis* meningitis confirmed by CSF and/or blood culture and PCR, or only confirmed by PCR

  Characteristics                                    CSF and/or blood culture and PCR positive (*n* = 67)   PCR positive (*n* = 43)                     *P* value[a](#tf0045){ref-type="table-fn"}
  -------------------------------------------------- ------------------------------------------------------ ------------------------------------------- --------------------------------------------
  General information                                                                                                                                   
   Age, median (IQR)                                 48 (38--56)                                            53 (45--61)                                 0.026
   Male sex (*n*, %)                                 57 (85.1)                                              34 (79.1)                                   0.416
   Residence (rural) (*n*, %)                        53 (79.1)                                              32 (74.41)                                  0.567
  Underlying diseases and exposure                                                                                                                      
   Diabetes mellitus (*n*, %)                        1 (1.5)                                                6 (13.0)                                    0.010
   Alcoholism (*n*, %)                               8 (11.9)                                               2 (4.7)                                     0.194
   Pig exposure (*n*, %)                             26 (38.8)                                              14 (32.6)                                   0.506
  Clinical manifestations                                                                                                                               
   Days of illness, median (IQR)                     3 (3--5)                                               5 (4--7)                                    0.004
   Antimicrobial therapy before admission (*n*, %)   35 (53.2)                                              38 (88.4)                                   \<0.001
   Fever (*n*, %)                                    65 (97.0)                                              42 (97.7)                                   0.522
   Headache (*n*, %)                                 67 (100)                                               42 (97.7)                                   0.391
   Nausea/vomiting (*n*, %)                          49 (73.1)                                              27 (62.8)                                   0.252
   Neck stiffness (*n*, %)                           61 (91.0)                                              40 (93.0)                                   1.000
   Glasgow Coma Score, median (IQR)                  12 (9--14)                                             13 (9--15)                                  0.159
   Tinnitus (*n*, %)                                 50 (74.6)                                              27 (62.8)                                   0.118
   Deafness (*n*, %)                                 19 (28.4)                                              11 (25.6)                                   0.714
   Skin injuries (*n*, %)                            18 (26.9)                                              13 (30.2)                                   0.702
   Herpes labialis (*n*, %)                          29 (43.3)                                              21 (48.8)                                   0.568
  Laboratory investigations median (IQR)                                                                                                                
   ▪ Blood                                                                                                                                              
     White blood cells (10^3^/L)                     18 000 (12 400--23 000)                                16 840 (12 600--23 550)                     0.941
     Neutrophil (%)                                  88 (83--91)                                            86.3 (80.3--90)                             0.131
   ▪ CSF                                                                                                                                                
     White cells (10^3^/L)                           1570 (760--3480)                                       1340 (340--2900)                            0.153
     Neutrophil (%)                                  86 (74--91)                                            70 (49--85)                                 0.002
     Protein (g/L)                                   1.6 (1.3--2)                                           1.63 (1.2--2)                               0.402
     CSF/blood glucose ratio                         0.24 (0.15--0.31)                                      0.40 (0.29--0.5)                            \<0.001
     Lactate (mmol/L)                                11.2 (6.8--15.7)                                       5.73 (4.4--8.3)                             \<0.001
  Outcome (survival)                                 67 (100)                                               40 (100)[b](#tf0050){ref-type="table-fn"}   

Determined using Fisher exact test or Wilcoxon rank-sum test, as appropriate.

Three patients were transferred to other hospitals and their outcomes are unknown.
